Early‐like differentiation status of systemic PD‐1(+) CD8 (+) T cells predicts PD‐1 blockade outcome in non‐small cell lung cancer

OBJECTIVES: Despite remarkable advances in the treatment of non‐small cell lung cancer (NSCLC) with anti‐programmed death (PD)‐1 therapy; only a fraction of patients derives durable clinical benefit. In this study, we investigated whether the differentiation status of systemic CD8(+) T cells predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanniche, Asma, Yang, Yi, Zhang, Jie, Liu, Shiqing, Xia, Liliang, Duan, Huangqi, Yao, Yaxian, Zhao, Bingrong, Zhao, Guo‐Ping, Hu, Chengping, Wang, Ying, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327560/
https://www.ncbi.nlm.nih.gov/pubmed/35910005
http://dx.doi.org/10.1002/cti2.1406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327560/
https://www.ncbi.nlm.nih.gov/pubmed/35910005
http://dx.doi.org/10.1002/cti2.1406

Ejemplares similares